--- title: Simsen News & Stories | Pontus Rehn description: "The latest from Simsen Diagnostics: partnerships, clinical trial collaborations, events and our perspective on tumour-informed ctDNA monitoring." --- [Skip to the main content.](https://simsendiagnostics.com/news/author/pontus-rehn#main-content) [![Simsen logotype](https://simsendiagnostics.com/hs-fs/hubfs/SD_logo%20medium-2.png?width=588&height=164&name=SD_logo%20medium-2.png "Simsen logotype")](https://simsendiagnostics.com) [![Simsen logotype](https://simsendiagnostics.com/hs-fs/hubfs/SD_logo%20medium-2.png?width=588&height=164&name=SD_logo%20medium-2.png "Simsen logotype")](https://simsendiagnostics.com) - [PLATFORM](https://simsendiagnostics.com/platform) - [Why Simsen](https://simsendiagnostics.com/why-simsen) - [Our technology](https://simsendiagnostics.com/platform-our-technology) - [Methodology](https://simsendiagnostics.com/platform-methodology) - [Find your approach](https://simsendiagnostics.com/find-your-approach) - [Delivered your way](https://simsendiagnostics.com/both-delivery-models) - [Solutions](https://simsendiagnostics.com/solutions-overview) - [EVIDENCE](https://simsendiagnostics.com/evidence-hub) - [Publications](https://simsendiagnostics.com/evidence-publications) - [Paediatric solid tumours](https://simsendiagnostics.com/evidence-paediatric-solid-tumours) - [CNS tumours & CSF ctDNA](https://simsendiagnostics.com/evidence-cns-csf-ctdna) - [White papers](https://simsendiagnostics.com/evidence-white-paper-ctdna-trials) - [COMPANY](https://simsendiagnostics.com/company-about) - [About us](https://simsendiagnostics.com/company-about) - [Team](https://simsendiagnostics.com/company-team) - [Contact us](https://simsendiagnostics.com/company-contact) - [News](https://simsendiagnostics.com/news) - [RESOURCES](https://simsendiagnostics.com/resources-hub) - [Sample collection guides](https://simsendiagnostics.com/resources-sample-collection-guides) - [Baseline kit guide](https://simsendiagnostics.com/baseline-collection-kit) - [Follow-up kit guide](https://simsendiagnostics.com/resources-followup-collection-kit) Search [![Request a conversation](https://hubspot-no-cache-eu1-prod.s3.amazonaws.com/cta/default/25734893/interactive-412216133822.png)](https://simsendiagnostics.com/hs/cta/wi/redirect?encryptedPayload=AVxigLLUH0wRlcY2V7DHo2daaqFU%2Fe6yvuU7Yu8bmYWM47JkD3xbn3EZ%2Fzf5fTAlTFFyrs1AFroiB7pSqlraBzSUnyEGt27fdWH8Wivr9yf8c8dzhGJlytqkns5FT3jXwuuQ13zh9zvA67aCZTkYDjpUqAsf%2BOjslGoabKJqgJr0NFt3TQxvnLkFHtINSv%2FPXO5rEHojcjHs&webInteractiveContentId=412216133822&portalId=25734893) Toggle Menu Search Toggle Menu [![Request a conversation](https://hubspot-no-cache-eu1-prod.s3.amazonaws.com/cta/default/25734893/interactive-412216133822.png)](https://simsendiagnostics.com/hs/cta/wi/redirect?encryptedPayload=AVxigLLUH0wRlcY2V7DHo2daaqFU%2Fe6yvuU7Yu8bmYWM47JkD3xbn3EZ%2Fzf5fTAlTFFyrs1AFroiB7pSqlraBzSUnyEGt27fdWH8Wivr9yf8c8dzhGJlytqkns5FT3jXwuuQ13zh9zvA67aCZTkYDjpUqAsf%2BOjslGoabKJqgJr0NFt3TQxvnLkFHtINSv%2FPXO5rEHojcjHs&webInteractiveContentId=412216133822&portalId=25734893) - [PLATFORM](https://simsendiagnostics.com/platform) - [Why Simsen](https://simsendiagnostics.com/why-simsen) - [Our technology](https://simsendiagnostics.com/platform-our-technology) - [Methodology](https://simsendiagnostics.com/platform-methodology) - [Find your approach](https://simsendiagnostics.com/find-your-approach) - [Delivered your way](https://simsendiagnostics.com/both-delivery-models) - [Solutions](https://simsendiagnostics.com/solutions-overview) - [EVIDENCE](https://simsendiagnostics.com/evidence-hub) - [Publications](https://simsendiagnostics.com/evidence-publications) - [Paediatric solid tumours](https://simsendiagnostics.com/evidence-paediatric-solid-tumours) - [CNS tumours & CSF ctDNA](https://simsendiagnostics.com/evidence-cns-csf-ctdna) - [White papers](https://simsendiagnostics.com/evidence-white-paper-ctdna-trials) - [COMPANY](https://simsendiagnostics.com/company-about) - [About us](https://simsendiagnostics.com/company-about) - [Team](https://simsendiagnostics.com/company-team) - [Contact us](https://simsendiagnostics.com/company-contact) - [News](https://simsendiagnostics.com/news) - [RESOURCES](https://simsendiagnostics.com/resources-hub) - [Sample collection guides](https://simsendiagnostics.com/resources-sample-collection-guides) - [Baseline kit guide](https://simsendiagnostics.com/baseline-collection-kit) - [Follow-up kit guide](https://simsendiagnostics.com/resources-followup-collection-kit) [For clinical trials Pharma and CROs Validate MRD endpoints, cut trial-arm cost, build EU regulatory readiness. Design a trial assay →](https://simsendiagnostics.com/solutions-trials) [For research and labs Translational oncology See signal in paediatric and early-stage samples your current platform misses. Send samples or run SiMSen-Seq in-house. See the signal →](https://simsendiagnostics.com/solutions-research) [For clinics Premium oncology monitoring Detect minimal residual disease ahead of imaging. Logistics across the EU, UK and EEA. Detect relapse earlier →](https://simsendiagnostics.com/solutions-clinic) [Home](https://simsendiagnostics.com/) / [Company](https://simsendiagnostics.com/company-about) / News News # *News* from Simsen. New partnerships and study collaborations, the events where you'll find us, and our thinking on tumour-informed ctDNA and where it's taking cancer care. [All](https://simsendiagnostics.com/news) [Corporate](https://simsendiagnostics.com/news/tag/corporate) [Customer](https://simsendiagnostics.com/news/tag/customer) [Interview](https://simsendiagnostics.com/news/tag/interview) [Corporate](https://simsendiagnostics.com/news/tag/corporate) 3 min read ### [Closing the gap between cancer research and patients is partly a question of where the test runs](https://simsendiagnostics.com/news/momentum2026-pre-event) Image: Solar Egg, Bigert & Bergström. Photo – Johan Strindberg Ahead of Momentum in Stockholm this October, a note on one lever for faster uptake … June 16, 2026, 3:23:28 PM GMT+02:00 [Corporate](https://simsendiagnostics.com/news/tag/corporate) 7 min read ### [From more treatment to smarter treatment: how tumour‑informed ctDNA monitoring can reduce harm and free capacity in cancer care](https://simsendiagnostics.com/news/from-more-treatment-to-smarter-treatment-how-tumour-informed-ctdna-monitoring-can-reduce-harm-and-free-capacity-in-nordic-cancer-care) Cancer services across the Nordics are under familiar pressure: rising incidence, tighter staffing, constrained imaging capacity, and a growing expect… December 17, 2025, 11:57:23 AM GMT+01:00 [Corporate](https://simsendiagnostics.com/news/tag/corporate) 1 min read ### [Simsen will attend the Swiss Nordic Bio 2025](https://simsendiagnostics.com/news/simsen-will-attend-the-swiss-nordic-bio-2025) Simsen Diagnostics is excited to announce its participation in the upcoming Swiss Nordic Bio 2025 conference, which will take place in Zurich on March… February 26, 2025, 5:21:49 PM GMT+01:00 [Customer](https://simsendiagnostics.com/news/tag/customer) 3 min read ### [Simsen announces collaboration with Buzzard Pharmaceuticals](https://simsendiagnostics.com/news/simsen-announces-collaboration-with-buzzard-pharmaceuticals) Gothenburg, 21 February 2025 Simsen Diagnostics Partners with Buzzard Pharmaceuticals for Isunakinra Colorectal Cancer Trial Simsen Diagnostics, a lea… February 21, 2025, 3:14:17 PM GMT+01:00 Talk to us ## Running a trial or service that needs this kind of signal? Tell us about your study and your endpoints. A real scientist in CET/CEST will reply. [Request a conversation](https://simsendiagnostics.com/start-a-conversation) [About Simsen](https://simsendiagnostics.com/company-about) ![full_lockup_white_CMYK kopia](https://simsendiagnostics.com/hs-fs/hubfs/full_lockup_white_CMYK%20kopia.png?width=166&height=45&name=full_lockup_white_CMYK%20kopia.png) **Visiting and postal address:** Pepparedsleden 1 431 53 Mölndal, Sweden **Shipping address:** c/o AstraZeneca R&D Mölndal Pepparedsleden 3 431 53 Mölndal, Sweden PLATFORM PLATFORM - [Platform overview](https://simsendiagnostics.com/platform) - [Why Simsen](https://simsendiagnostics.com/why-simsen) - [Our technology](https://simsendiagnostics.com/platform-our-technology) - [Delivered your way](https://simsendiagnostics.com/both-delivery-models) SOLUTIONS SOLUTIONS - [For clinical trials](https://simsendiagnostics.com/solutions-trials) - [For research and labs](https://simsendiagnostics.com/solutions-research) - [For clinics](https://simsendiagnostics.com/solutions-clinic) - [Solutions overview](https://simsendiagnostics.com/solutions-overview) COMPANY COMPANY - [About](https://simsendiagnostics.com/company-about) - [News](https://simsendiagnostics.com/news) - [Team](https://simsendiagnostics.com/company-team) - [Contact](https://simsendiagnostics.com/company-contact) - [Privacy policy](https://simsendiagnostics.com/legal-privacy-policy) - [Cookie Policy](https://simsendiagnostics.com/legal-cookie-policy) - [Terms of use](https://simsendiagnostics.com/legal-terms-of-use) © 2026 Simsen Diagnostics AB, All rights reserved. [Linkedin](https://www.linkedin.com/company/simsendiagnostics) Return to top